Ex-Ante-Transparenzbekanntmachung § 130c Abs. 1 SGB V Arzneimittelbezeichnung: Lixiana(R) Wirkstoff: Edoxaban ATC-Code: B01AF03
Deadline:N/A
Tender information
Germany
Type
Voluntary ex ante transparency
Procedure
Negotiated without a call for competition
Ref. number
26-065
Duration
2 years
Arzneimittelrabattvertrag § 130c Abs. 1 SGB V Arzneimittelbezeichnung: Lixiana(R) Wirkstoff: Edoxaban ATC-Code: B01AF03
Buyer
AOK Bayern - Die Gesundheitskasse
Documents
Buyer
AOK Bayern - Die Gesundheitskasse
No time limit
Important dates
22 Jun - Publication date
Unlock Full Access with Mercell Bidding Business Plus